Current guidelines recommend treating SCH with thyroid hormone replacement when TSH exceeds 10 mU l−1, if the patient is young, have a positive screen for thyroid-peroxidase antibodies (anti-TPO), have cardiovascular disease or exhibit symptoms of hypothyroidism4. Here, TPO is linked to cardiovascular disorder.